Overview
TIGERMED
?
Xiaochun Cao
See more contacts
Scientific Research and Development Services
,
Business Support Services
,
Professional, Scientific, and Technical Services
,
Medical research, commercial
,
Business services, nec
Accounting, Tax Preparation, Bookkeeping, and Payroll Services
,
Advertising, Public Relations, and Related Services
,
Architectural, Engineering, and Related Services
,
Computer Systems Design and Related Services
,
Legal Services
,
Management, Scientific, and Technical Consulting Services
,
Other Professional, Scientific, and Technical Services
,
Specialized Design Services
?
?
?
Actual
?
Actual
$911.34 million
Actual
-10.58%
-79.99%
$28,671
DEC
?
?
Shenzhen:300347
Contacts
Get in Touch with 8 Principals*
-
Xiaochun CaoExecutive Director
-
Contact 2?
-
Contact 3?
-
Contact 4?
Dynamic search and list-building capabilities
Real-time trigger alerts
Comprehensive company profiles
Valuable research and technology reports
Financial Statements
Dun & Bradstreet collects private company financials for more than 23 million companies worldwide. Find out more.
Financial data as of December 31, 2024 (12 month period) in USD
Annual Revenue 2024
$911.34 million
USD
Actual
1 USD = 7.2455 CNY
All financial statement data is in millions except per share data | Source: Morningstar
| Cash Flow (mil) | 2024 | 2023 | 2022 |
|---|---|---|---|
| Net Operating Cash | $151 | $159 | $187 |
| Net Investing Cash | -$654 | -$212 | -$385 |
| Net Financing Cash | -$235 | -$1 | $112 |
| Net Change in Cash | -$738 | -$54 | -$86 |
| Cash at Beginning of Period | $1,021 | $1,074 | $1,156 |
| Cash at End of Period | $283 | $1,021 | $1,074 |
| Capital Expenditure | -$49 | -$43 | -$62 |
| Assets (mil) | 2024 | 2023 | 2022 |
|---|---|---|---|
| Current Assets | |||
| Cash and Cash Equivalents | $284 | $1,024 | $1,085 |
| Accounts Receivable | $188 | $174 | $142 |
| Inventories | $4 | $3 | $3 |
| Other Current Assets | $394 | $364 | $304 |
| Asset Summary | |||
| Total Current Assets | $869 | $1,566 | $1,533 |
| Tangible Fixed Assets | $233 | $203 | $183 |
| Intangible Assets | $46 | $51 | $47 |
| Total Assets | $28,671 | $29,681 | $27,447 |
| Liabilities (mil) | 2024 | 2023 | 2022 |
|---|---|---|---|
| Current Liabilities | |||
| Accounts Payable | $36 | $34 | $22 |
| Short-Term Debt | $264 | $272 | $255 |
| Other Current Liabilities | $206 | $265 | $238 |
| Liability Summary | |||
| Total Current Liabilities | $505 | $571 | $515 |
| Long-Term Debt | $45 | $60 | $34 |
| Other Long-Term Liabilities | $ | $ | $ |
| Total Liabilities | $636 | $721 | $658 |
| Stakeholder's Equity (mil) | 2024 | 2023 | 2022 |
|---|---|---|---|
| Equity | |||
| Common Stock | $119 | $120 | $120 |
| Retained Earnings | $1,199 | $1,211 | $1,003 |
| Equity Summary | |||
| Total Equity | $2,853 | $2,902 | $2,703 |
| Shares Outstanding | 864,948,570 | 872,418,220 | 872,418,220 |